GLP-1
Treatment Review
← Peptide library

The evidence reference

Semaglutide

Wegovy

Approved product

Sources checked 2026-10-27

Reading this profile

Treat the name attached to a claim as something to verify. In a report, locate the exact product description before collecting its results. If a comparison page groups several products under an ingredient name, check whether each cited result belongs to the product being discussed. Keep a small record of the product, intended question, participants, and measurement alongside any headline. This makes it easier to spot a claim that has grown broader as it moves from a research report to a summary. An ingredient match alone would leave those other parts of the comparison unresolved.

Formulation and route

This entry covers subcutaneous Wegovy injection.

Mechanism

Activates the GLP-1 receptor.

Research evidence

Randomized trials.

Limits of the evidence

Check other products separately.

Safety context

Severe or persistent gastrointestinal symptoms: contact a clinician.

Questions to take further

  1. Does the report identify the same product described in the claim?
  2. Which details disappear when the result is shortened to an ingredient name?
  3. Can each comparison on the page be traced to a matching product description?

Original sources

  1. WEGOVYNLM · Checked 2026-10-27
  2. Wegovy approvalFDA · Checked 2026-10-27

Continue your research

An educational reference from the Comparison Desk. AI-assisted; not reviewed by a licensed clinician. This library does not provide prescriptions or instructions for self-treatment.